Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine (VEE C-84) as a Booster to VEE TC-83

Status unconfirmed · Phase 2

Conditions studied: Venezuelan Equine Encephalomyelitis

In brief

The study is designed to assess the safety and immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine, Inactivated, Dried, C-84, TSI GSD 205, as a booster vaccination.

Key facts

Study ID
NCT00582088
Run by
U.S. Army Medical Research and Development Command
People needed
500
Starts
2008-03-01
Expected to finish
2021-12-01
Last updated by the study team
2021-02-11

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.